Suppr超能文献

感染性角膜炎:介导角膜损伤的细菌分泌蛋白。

Infectious keratitis: secreted bacterial proteins that mediate corneal damage.

作者信息

Marquart Mary E, O'Callaghan Richard J

机构信息

Department of Microbiology, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS 39216, USA.

出版信息

J Ophthalmol. 2013;2013:369094. doi: 10.1155/2013/369094. Epub 2013 Jan 8.

Abstract

Ocular bacterial infections are universally treated with antibiotics, which can eliminate the organism but cannot reverse the damage caused by bacterial products already present. The three very common causes of bacterial keratitis-Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae-all produce proteins that directly or indirectly cause damage to the cornea that can result in reduced vision despite antibiotic treatment. Most, but not all, of these proteins are secreted toxins and enzymes that mediate host cell death, degradation of stromal collagen, cleavage of host cell surface molecules, or induction of a damaging inflammatory response. Studies of these bacterial pathogens have determined the proteins of interest that could be targets for future therapeutic options for decreasing corneal damage.

摘要

眼部细菌感染通常使用抗生素进行治疗,抗生素可以消灭病原体,但无法逆转已经存在的细菌产物所造成的损害。细菌性角膜炎的三个非常常见的病因——铜绿假单胞菌、金黄色葡萄球菌和肺炎链球菌——都会产生蛋白质,这些蛋白质直接或间接对角膜造成损害,即使经过抗生素治疗,也可能导致视力下降。这些蛋白质中的大多数(但不是全部)是分泌性毒素和酶,它们介导宿主细胞死亡、基质胶原蛋白降解、宿主细胞表面分子裂解或引发有害的炎症反应。对这些细菌病原体的研究已经确定了一些值得关注的蛋白质,它们可能成为未来减少角膜损伤的治疗选择的靶点。

相似文献

1
Infectious keratitis: secreted bacterial proteins that mediate corneal damage.
J Ophthalmol. 2013;2013:369094. doi: 10.1155/2013/369094. Epub 2013 Jan 8.
2
Pharmacokinetic considerations in the treatment of bacterial keratitis.
Clin Pharmacokinet. 1994 Aug;27(2):129-49. doi: 10.2165/00003088-199427020-00005.
3
Pivotal Role of Corneal Fibroblasts in Progression to Corneal Ulcer in Bacterial Keratitis.
Int J Mol Sci. 2021 Aug 20;22(16):8979. doi: 10.3390/ijms22168979.
4
Proteomics in the Study of Bacterial Keratitis.
Proteomes. 2015 Dec 14;3(4):496-511. doi: 10.3390/proteomes3040496.
7
Corneal Fibroblasts as Sentinel Cells and Local Immune Modulators in Infectious Keratitis.
Int J Mol Sci. 2017 Aug 23;18(9):1831. doi: 10.3390/ijms18091831.
8
[Therapeutic efficacy of ultraviolet combined with riboflavin for the rabbit bacterial keratitis].
Zhonghua Yan Ke Za Zhi. 2018 Dec 11;54(12):902-910. doi: 10.3760/cma.j.issn.0412-4081.2018.12.007.
9
Ocular Permeation of Topical Tazocin and Its Effectiveness in the Treatment of Pseudomonas aeruginosa Induced Keratitis in Rabbits.
J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):214-223. doi: 10.1089/jop.2017.0098. Epub 2018 Jan 17.
10
Disarming Pore-Forming Toxins with Biomimetic Nanosponges in Intraocular Infections.
mSphere. 2019 May 15;4(3):e00262-19. doi: 10.1128/mSphere.00262-19.

引用本文的文献

1
Metallic nano-warriors: Innovations in nanoparticle-based ocular antimicrobials.
Mater Today Bio. 2024 Sep 14;28:101242. doi: 10.1016/j.mtbio.2024.101242. eCollection 2024 Oct.
2
Neutrophils in Ocular Diseases.
Int J Mol Sci. 2024 Jul 15;25(14):7736. doi: 10.3390/ijms25147736.
6
Thymosin beta 4: A potential novel adjunct treatment for bacterial keratitis.
Int Immunopharmacol. 2023 May;118:109953. doi: 10.1016/j.intimp.2023.109953. Epub 2023 Apr 3.
8
Recent Applications of Contact Lenses for Bacterial Corneal Keratitis Therapeutics: A Review.
Pharmaceutics. 2022 Nov 28;14(12):2635. doi: 10.3390/pharmaceutics14122635.
10
Ocular Surface Infection Mediated Molecular Stress Responses: A Review.
Int J Mol Sci. 2022 Mar 14;23(6):3111. doi: 10.3390/ijms23063111.

本文引用的文献

1
Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor.
Invest Ophthalmol Vis Sci. 2013 Apr 17;54(4):2821-8. doi: 10.1167/iovs.13-11788.
2
Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus.
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9107-12. doi: 10.1073/pnas.1202869109. Epub 2012 May 14.
3
Childhood microbial keratitis.
Oman J Ophthalmol. 2012 Jan;5(1):28-31. doi: 10.4103/0974-620X.94763.
5
Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.
Clin Infect Dis. 2012 May;54(10):1381-7. doi: 10.1093/cid/cis189. Epub 2012 Mar 23.
9
Identification and potency of cyclodextrin-lipid inhibitors of Staphylococcus aureus α-toxin.
Curr Eye Res. 2012 Feb;37(2):87-93. doi: 10.3109/02713683.2011.624669. Epub 2011 Nov 3.
10
Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.
Invest Ophthalmol Vis Sci. 2011 Nov 29;52(12):9232-43. doi: 10.1167/iovs.10-6968.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验